JWM
VRTX icon

Janiczek Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Janiczek Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$423K Buy
903
+202
+29% +$87.7K 0.09% 94
2024
Q1 		$293K Buy
701
+120
+21% +$50.7K 0.06% 135
2023
Q4 		$236K Buy
581
+18
+3% +$6.65K 0.06% 140
2023
Q3 		$196K Buy
563
+257
+84% +$89.9K 0.05% 145
2023
Q2 		$108K Buy
306
+38
+14% +$12.8K 0.03% 202
2023
Q1 		$89.4K Buy
268
+55
+26% +$16.5K 0.03% 232
2022
Q4 		$63.1K Buy
213
+24
+13% +$7.31K 0.02% 285
2022
Q3 		$56K Sell
189
-7
-4% -$2.01K 0.02% 290
2022
Q2 		$55K Buy
196
+14
+8% +$3.75K 0.02% 292
2022
Q1 		$47K Buy
182
+49
+37% +$11.6K 0.01% 312
2021
Q4 		$29K Buy
133
+67
+102% +$13K 0.01% 422
2021
Q3 		$12K Buy
66
+19
+40% +$3.71K ﹤0.01% 552
2021
Q2 		$9K Sell
47
-16
-25% -$3.35K ﹤0.01% 577
2021
Q1 		$14K Sell
63
-62
-50% -$13.6K 0.01% 469
2020
Q4 		$30K Buy
125
+116
+1,289% +$26.6K 0.01% 283
2020
Q3 		$2K Sell
9
-5
-36% -$1.38K ﹤0.01% 530
2020
Q2 		$4K Buy
+14
New +$3.8K ﹤0.01% 218

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Janiczek Wealth Management's VRTX Position: Q2 2024 in Review

Janiczek Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 29% in Q2 2024, buying an estimated $87.7K and bringing the position to 903 shares worth $423K. The position accounts for 0.09% of the portfolio, ranked #94.

Janiczek Wealth Management first reported a position in VRTX in Q2 2020 and has held it in 17 quarters since. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • Janiczek Wealth Management held 903 shares of Vertex Pharmaceuticals worth $423K as of Q2 2024.
  • Janiczek Wealth Management bought 202 Vertex Pharmaceuticals shares in Q2 2024, an estimated $87.7K.
  • Vertex Pharmaceuticals made up 0.09% of Janiczek Wealth Management's portfolio in Q2 2024, its #94 holding.
  • Janiczek Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 17 quarters since.
  • 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.